Physician profile
Michelle Ross
NPI 1871612895
$1,030.48
in general payments reported to CMS, 2019-2025
11 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $147 · 2023: $209 · 2024: $237 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $320.37 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $296.09 | 2021-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.91 | 2022-2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $71.11 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $63.46 | 2023-2025 | Farxiga |
| Scpharmaceuticals INC. | $55.97 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $54.42 | 2021-2025 | Eliquis |
| Medtronic, INC. | $33.07 | 2024-2025 | Onyx Frontier, Ffrangio |
| Alnylam Pharmaceuticals INC. | $25.04 | 2025 | |
| Boston Scientific Corporation | $20.27 | 2022 | |
| Abbvie INC. | $17.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.